Quantcast

Latest Controlled Substances Act Stories

2011-02-17 06:00:00

RALEIGH, N.C., Feb. 17, 2011 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that enrollment of its Phase 3 trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain is on schedule, with over half of the needed subjects enrolled. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) "We are very pleased with the enrollment to date for this pivotal Phase 3 study for our next...

2011-01-28 07:30:00

RARITAN, N.J., Jan. 28, 2011 /PRNewswire/ -- New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication. This phase III study, which evaluates the safety and efficacy of tapentadol ER against placebo for relieving moderate to severe chronic pain associated with diabetic peripheral neuropathy (DPN), is...

2010-09-14 07:56:00

Survey of Police and Teachers: Alcohol and Marijuana Most Serious Substance Abuse Facing Teens NEW YORK, Sept. 14 /PRNewswire-USNewswire/ -- The Center for Medicine in the Public Interest released the results of a national Teen Substance Abuse survey today, indicating that police officers and high school teachers nationwide believe alcohol and marijuana are the most serious problem substances facing teenagers. These survey results come as the Food and Drug Administration has scheduled an...

2010-09-09 10:02:00

Upcoming FDA Hearing on Abuse of Cough and Cold Medications Misses the Mark NEW YORK, Sept. 9 /PRNewswire-USNewswire/ -- The Center for Medicine in the Public Interest released the results of a national Teen Substance Abuse survey today, indicating that police officers and high school teachers nationwide believe alcohol and marijuana are the most serious problem substances facing teenagers. These survey results come as the Food and Drug Administration has scheduled an Advisory Committee...

2010-08-30 14:37:00

RARITAN, N.J., Aug. 30 /PRNewswire/ -- Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation. In addition, this study compared oxycodone controlled release (CR) to placebo as an active control. Tapentadol ER vs. Placebo The study demonstrated that a significantly higher percentage of patients...

2010-08-18 06:00:00

LOS ANGELES, Aug. 18 /PRNewswire/ -- On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location. More info at http://www.mass.gov/legis/laws/seslaw10/sl100283.htm. To help pharmacies comply...

2010-08-09 14:30:00

CHADDS FORD, Pa., Aug. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals (Nasdaq: PPCO) for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization...

2010-06-18 15:22:00

DETROIT, June 18 /PRNewswire/ -- Today, the Drug Enforcement Administration and U.S. Attorney's Office, and Harvard Drug Group announced their agreement to immediately modify the suspension, upon certain conditions, of Harvard's registration to distribute schedule III through V controlled substances out of its Livonia Distribution Center, and a mutual commitment to commence discussions, towards resolution of the issues raised in the DEA's suspension order. The suspension remains as to...

2010-05-07 07:00:00

BALTIMORE, May 7 /PRNewswire/ -- A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain. These data will be presented during a poster session today at the 29th Annual Scientific Meeting of the American Pain Society (APS), and...

2010-03-24 13:48:00

AHCA/NCAL Members Testify Before Senate Committee WASHINGTON, March 24 /PRNewswire-USNewswire/ -- The American Health Care Association and the National Center for Assisted Living (AHCA/NCAL) praised Senator Herb Kohl (D-WI) and the other Members of the U.S. Senate Special Committee on Aging for their efforts to address delays with dispensing of critical pain medications for patients in nursing homes, assisted living communities, and hospice. These delays, which stem from recent Drug...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.